MoonLake Immunotherapeutics

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KY61559X1045
USD
15.62
-31 (-66.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Apellis Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
Alkermes Plc
Intra-Cellular Therapies, Inc.
ACADIA Pharmaceuticals, Inc.
Perrigo Co. Plc
Organon & Co.
Insmed, Inc.
Karuna Therapeutics, Inc.
Cerevel Therapeutics Holdings, Inc.
MoonLake Immunotherapeutics

Why is MoonLake Immunotherapeutics ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is MoonLake Immunotherapeutics for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
MoonLake Immunotherapeutics
-100.0%
-0.62
108.92%
S&P 500
13.66%
0.81
19.85%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-475.84%
EBIT to Interest (avg)
-75.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.00
Sales to Capital Employed (avg)
0
Tax Ratio
0.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.39
EV to EBIT
-15.25
EV to EBITDA
-15.41
EV to Capital Employed
1412.25
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9260.06%
ROE (Latest)
-36.27%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at USD -95.16 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-31What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -166.41 MM

ROCE(HY)

Lowest at -40.29%

DEBT-EQUITY RATIO (HY)

Highest at -98.75 %

INTEREST(Q)

Highest at USD 2.04 MM

OPERATING PROFIT(Q)

Lowest at USD -59.96 MM

PRE-TAX PROFIT(Q)

Lowest at USD -55.96 MM

NET PROFIT(Q)

Lowest at USD -55.22 MM

EPS(Q)

Lowest at USD -0.87

Here's what is working for MoonLake Immunotherapeutics

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MoonLake Immunotherapeutics

Pre-Tax Profit
At USD -55.96 MM has Fallen at -126.73%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -55.22 MM has Fallen at -127.55%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -166.41 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest
At USD 2.04 MM has Grown at 11,216.67%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest
Highest at USD 2.04 MM
in the last five periods and Increased by 11,216.67% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit
Lowest at USD -59.96 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -55.96 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -55.22 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.87
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio
Highest at -98.75 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio